Latest Period
Q4 2025
Security Snapshot
Celularity Inc - Class A Common Stock, $0.0001 par value per share (CELU) Institutional Ownership
CUSIP: 151190204
13F Institutional Holders and Ownership History from Q1 2024 to Q1 2026
Institutions Reporting
35
Shares (Excl. Options)
1,449,435
Price
$1.11
- Type / Class
- Equity / Class A Common Stock, $0.0001 par value per share
- Symbol
- CELU on Nasdaq
- Shares outstanding
- 23,944,922
- Price per share
- $1.33
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 1,449,435
- Total reported value
- $1,608,923
- % of total 13F portfolios
- 0%
- Share change
- -86,313
- Value change
- -$277,872
- Number of holders
- 35
- Price from insider filings
- $1.33
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- CELU - Celularity Inc - Class A Common Stock, $0.0001 par value per share is tracked under CUSIP 151190204.
- 35 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 35 to 1 between Q4 2025 and Q1 2026.
- Reported value moved from $1,608,923 to $665.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 151190204?
CUSIP 151190204 identifies CELU - Celularity Inc - Class A Common Stock, $0.0001 par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 151190204:
Significant Owners of Celularity Inc - Class A Common Stock, $0.0001 par value per share (CELU) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Dragasac Ltd | 41% | +13% | $27,710,796 | +$8,232,000 | 14,138,161 | +42% | Lim Kok Thay | 24 Jul 2025 |
As of 31 Dec 2025, 35 institutional investors reported holding 1,449,435 shares of Celularity Inc - Class A Common Stock, $0.0001 par value per share (CELU). This represents 6.1% of the company’s total 23,944,922 outstanding shares.
Institutional Holders of Celularity Inc - Class A Common Stock, $0.0001 par value per share (CELU) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 500 | $665 | $1.33 | 1 | |
| 2025 Q4 | 1,449,435 | $1,608,923 | -$277,872 | $1.11 | 35 |
| 2025 Q3 | 2,299,817 | $4,755,556 | +$256,110 | $2.07 | 38 |
| 2025 Q2 | 2,177,848 | $4,267,509 | +$13,254 | $1.96 | 34 |
| 2025 Q1 | 1,981,476 | $3,426,607 | +$205,139 | $1.73 | 29 |
| 2024 Q4 | 1,850,085 | $3,848,006 | +$219,913 | $2.08 | 31 |
| 2024 Q3 | 964,511 | $2,864,555 | +$21,256 | $2.97 | 26 |
| 2024 Q2 | 944,761 | $2,956,741 | +$298,532 | $3.13 | 26 |
| 2024 Q1 | 836,863 | $4,377,386 | +$4,294,925 | $5.23 | 30 |